We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Martina Porter

Martina L. Porter MD

Dermatologist, Beth Israel Deaconess Medical Center; Co-Director, Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Beth Israel Deaconess Medical Center, Boston, Massachusetts

Martina Porter, MD, completed her dermatology residency training at Roger Williams Medical Center. Through the American Board of Dermatology’s Special Investigative Training Track, she spent her third year of residency as a Clinical and Research Fellow at Massachusetts General Hospital with a focus on clinical trials.  She also completed an additional research fellowship at Beth Israel Deaconess Medical Center where she started a new clinical trials unit, the Clinical Laboratory for Epidemiology and Applied Research (CLEARS), with Dr. Alexa Kimball, that she now directs.  She has developed an expertise in Hidradenitis Suppurativa, the design and conduct of clinical trials, and the development and validation of disease-specific scoring systems.  Her specific research interests include Women’s Health, Quality improvement, Psoriasis, Hidradenitis Suppurativa, and Alopecia.

Disclosures

Dr. Porter is a consultant and/or investigator for Abbvie, Bristol Meyers Squibb, Janssen, Eli Lilly, Novartis, Pfizer, UCB, Trifecta Clinical, Incyte, and Anaptys Bio.